CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

mHealth AssessmentsWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation

Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug679 Inhaled budesonide Wiki 1.00

Correlated MeSH Terms (3)

Name (Synonyms) Correlation
D011014 Pneumonia NIH 0.07
D045169 Severe Acute Respiratory Syndrome NIH 0.06
D018352 Coronavirus Infections NIH 0.05

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.07

There is one clinical trial.

Clinical Trials

1 Mobile Health Study and Enhanced Symptom Monitoring to Prevent Severe Illness From COVID-19 in Cancer Patients

The established Insight(TM) mHealth Platform, a component of the Stephenson Cancer Center (SCC) mHealth Shared Resource will be used to create the "Symptom Tracker" app. The Symptom Tracker (Insight(TM)) app will enable real-time monitoring of cancer patient symptoms that are consistent with early signs of SARS-CoV-2 infection in this high-risk population by automatically (and securely) transferring this information to health care providers. The primary aim of this study is to determine the feasibility, ease of use, and perceived utility of this app to monitor symptoms and health risk behaviors among cancer patients currently receiving chemotherapy.

NCT04397614 Sars-CoV2 Covid-19 Other: mHealth Assessments

Primary Outcomes

Measure: Percentage of ecological momentary assessments completed

Time: up to 24 weeks

Measure: Percentage of satisfied mHealth app users

Time: up to 24 weeks

Secondary Outcomes

Measure: Proportion of manifestation of severe disease

Time: up to 24 weeks

Measure: Proportion of treatment-related toxicity

Time: up to 24 weeks

Measure: Proportion of hospitalization

Time: up to 24 weeks

Measure: Proportion of COVID-19 related mortality

Time: up to 24 weeks

No related HPO nodes (Using clinical trials)